# Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platform (VIP) Vascular Closure Device

> **NCT01858636** · — · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 235 (actual)

## Conditions studied

- Vascular Closure

## Interventions

- **DEVICE:** Angio-Seal VIP 6 French (6F) and 8 French (8F) devices

## Key facts

- **NCT ID:** NCT01858636
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 235 (ACTUAL)
- **Last updated:** 2019-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01858636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01858636, "Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platform (VIP) Vascular Closure Device". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01858636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*